Predictive Oncology Inc. (POAI) Earnings History
Net Loss17 years of earnings data (2008–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Predictive Oncology Inc. (POAI) Earnings Overview
As of June 28, 2026, Predictive Oncology Inc. (POAI) reported trailing twelve-month net income of -$84M, reflecting +35.6% year-over-year growth. The company earned $-116.48 per diluted share over the past four quarters, with a net profit margin of -751.4%.
Looking at the long-term picture, POAI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1M in fiscal 2010.
Predictive Oncology Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RXRX (-$560M net income, -863.4% margin), ABSI (-$118M net income, -4113.7% margin), SDGR (-$103M net income, -40.4% margin), POAI has outperformed on profitability metrics. Compare POAI vs RXRX →
POAI Earnings vs Peers
Earnings metrics vs comparable public companies
POAI Historical Earnings Data (2008–2024)
17 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$12M | +12.7% | -$11M | $-2.24 | -751.4% | -673.7% |
| 2023 | -$14M | +45.7% | -$12M | $-3.48 | -859.1% | -744.5% |
| 2022 | -$26M | -30.9% | -$26M | $-6.98 | -1709.6% | -1729.3% |
| 2021 | -$20M | +24.1% | -$20M | $-7.20 | -1383.6% | -1437.9% |
| 2020 | -$26M | -33.5% | -$25M | $-44.25 | -2067.0% | -2025.1% |
| 2019 | -$19M | -92.2% | -$23M | $-137.20 | -1373.7% | -1604.2% |
| 2018 | -$10M | -30.2% | -$8M | $-157.40 | -714.5% | -556.9% |
| 2017 | -$8M | -18.7% | -$8M | $-188.69 | -1183.0% | -1183.0% |
| 2016 | -$7M | -36.2% | -$7M | $-462.28 | -1429.6% | -1429.6% |
| 2015 | -$5M | +29.9% | -$4M | $-306.79 | -732.1% | -672.4% |
| 2014 | -$7M | +27.4% | -$6M | $-737.17 | -718.1% | -679.7% |
| 2013 | -$9M | -26.7% | -$9M | $-1070.11 | -2009.4% | -1907.1% |
| 2012 | -$7M | -65.4% | -$7M | $-1786.32 | -3931.8% | -3792.8% |
| 2011 | -$4M | -231.7% | -$4M | $-52786.81 | -4643.0% | -4248.3% |
| 2010 | -$1M | +53.2% | -$1M | $-609.33 | -469690.6% | -418616.7% |
| 2009 | -$3M | -64.1% | -$2M | $-1606.79 | -18378.5% | -15528.1% |
| 2008 | -$2M | - | -$2M | $-2562.50 | - | - |
Download Data
Export POAI earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
18+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
POAI — Frequently Asked Questions
Quick answers to the most common questions about buying POAI stock.
What is POAI earnings per share (EPS)?
POAI trailing twelve-month (TTM) diluted EPS is $-116.48, reflecting +35.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2008 to 2024 is available in the table on this page.
What is Predictive Oncology Inc.'s net income?
Predictive Oncology Inc. (POAI) trailing twelve-month net income is $-84M as of 2024. Earnings grew +35.6% year-over-year.
Is POAI profitable?
POAI is not currently profitable on a TTM basis, reporting a net loss of $-84M. Net margin is -751.4%. Investors should monitor for a return to profitability.
What is POAI's earnings growth rate?
POAI compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2008 to 2024.
What are POAI's profit margins?
Predictive Oncology Inc. net profit margin is -751.4%, operating margin is -673.7%, and gross margin is +49.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is -302.4%.
Is POAI growing earnings?
Yes, POAI earnings are accelerating — EPS growth of +35.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-84M. Earnings momentum is strengthening.
What was POAI's best earnings year?
Predictive Oncology Inc.'s highest annual net income on record is $-1M, achieved in fiscal year 2010. Earnings history on this page spans 2008 to 2024 and includes all annual and quarterly figures.
What were POAI's earnings last quarter?
POAI's most recent reported quarter was Q3 2025. Net income was $-78M with diluted EPS of $-107.25. For a full breakdown of all quarters, see the quarterly earnings table on this page.